U.S. Markets close in 3 hrs 33 mins

Cabot Corp (CBT) Files 10-K for the Fiscal Year Ended on September 30, 2018

- By insider

Cabot Corp (CBT) files its latest 10-K with SEC for the fiscal year ended on September 30, 2018. Cabot Corp is a specialty chemicals and performance materials Company. The Company offers rubber and specialty grade carbon blacks, fumed metal oxides, inkjet colorants, aerogel, cesium formate drilling fluids and activated carbon. Cabot Corp has a market cap of $2.9 billion; its shares were traded at around $48.02 with and P/S ratio of 0.92. The dividend yield of Cabot Corp stocks is 2.69%.

For the last quarter Cabot Corp reported a revenue of $850.0 million, compared with the revenue of $723.0 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $3.2 billion, an increase of 19.3% from last year. For the last five years Cabot Corp had an average revenue decline of 3.9% a year.

The reported loss per diluted share was $1.872 for the year, compared with the earnings per share of $2.36 in the previous year. The Cabot Corp had a decent operating margin of 12.65%, compared with the operating margin of 12.37% a year before. The 10-year historical median operating margin of Cabot Corp is 8.69%. The profitability rank of the company is 5 (out of 10).

At the end of the fiscal year, Cabot Corp has the cash and cash equivalents of $175.0 million, compared with $280.0 million in the previous year. The long term debt was $719.0 million, compared with $661.0 million in the previous year. The interest coverage to the debt is 7.6. Cabot Corp has a financial strength rank of 6 (out of 10).

At the current stock price of $48.02, Cabot Corp is traded at 10.5% premium to its historical median P/S valuation band of $43.45. The P/S ratio of the stock is 0.92, while the historical median P/S ratio is 0.83. The stock lost 20.32% during the past 12 months.

For the complete 20-year historical financial data of CBT, click here.

This article first appeared on GuruFocus.